• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The economics of haemophilia prophylaxis: governmental and insurer perspectives. Proceedings of the Second International Prophylaxis Study Group (IPSG) symposium.

作者信息

Feldman B M, Aledort L, Bullinger M, Delaney F M, Doria A S, Funk S, Giangrande P, Lundin B, Manco-Johnson M, Miners A, Scriba P C, Srivastava A, Schramm W, Blanchette V S

机构信息

Department of Pediatrics, University of Toronto, and Division of Rheumatology, The Hospital for Sick Children, Toronto, Ontario, Canada.

出版信息

Haemophilia. 2007 Nov;13(6):745-9. doi: 10.1111/j.1365-2516.2007.01542.x. Epub 2007 Sep 10.

DOI:10.1111/j.1365-2516.2007.01542.x
PMID:17850325
Abstract
摘要

相似文献

1
The economics of haemophilia prophylaxis: governmental and insurer perspectives. Proceedings of the Second International Prophylaxis Study Group (IPSG) symposium.
Haemophilia. 2007 Nov;13(6):745-9. doi: 10.1111/j.1365-2516.2007.01542.x. Epub 2007 Sep 10.
2
Treatment for life for severe haemophilia A- A cost-utility model for prophylaxis vs. on-demand treatment.用于治疗重型 A 型血友病的方案-预防治疗与按需治疗的成本效用模型。
Haemophilia. 2013 Jul;19(4):e228-38. doi: 10.1111/hae.12121. Epub 2013 Mar 28.
3
Recommendations for reporting economic evaluations of haemophilia prophylaxis: a nominal groups consensus statement on behalf of the Economics Expert Working Group of The International Prophylaxis Study Group.血友病预防措施经济评估报告建议：代表国际预防研究小组经济专家工作组的名义小组共识声明
Haemophilia. 2008 Jan;14(1):127-32. doi: 10.1111/j.1365-2516.2007.01562.x. Epub 2007 Nov 13.
4
Cost-utility analysis of primary prophylaxis versus treatment on-demand for individuals with severe haemophilia.重度血友病患者一级预防与按需治疗的成本效益分析。
Pharmacoeconomics. 2002;20(11):759-74. doi: 10.2165/00019053-200220110-00005.
5
Consensus perspectives on prophylactic therapy for haemophilia: summary statement.血友病预防性治疗的共识观点：总结声明
Haemophilia. 2003 May;9 Suppl 1:1-4. doi: 10.1046/j.1365-2516.9.s1.17.x.
6
Economics of prophylactic treatment.预防性治疗的经济学
Haemophilia. 2003 May;9 Suppl 1:111-5; dicussion 116. doi: 10.1046/j.1365-2516.9.s1.14.x.
7
Influence of medical insurance schemes and charity assistance projects on regular prophylaxis treatment of the boys with severe haemophilia A in China.医疗保险方案和慈善援助项目对中国重度甲型血友病男童常规预防治疗的影响。
Haemophilia. 2018 Jan;24(1):126-133. doi: 10.1111/hae.13372. Epub 2017 Nov 17.
8
Cost-effectiveness analysis of late prophylaxis vs. on-demand treatment for severe haemophilia A in Italy.意大利重度甲型血友病延迟预防与按需治疗的成本效益分析。
Haemophilia. 2017 May;23(3):422-429. doi: 10.1111/hae.13185. Epub 2017 Feb 8.
9
High cost patients and the consortium approach.高成本患者与联合治疗方法。
Pathophysiol Haemost Thromb. 2002;32 Suppl 1:26-8. doi: 10.1159/000057297.
10
Haemophilia A: pharmacoeconomic review of prophylaxis treatment versus on-demand.甲型血友病：预防治疗与按需治疗的药物经济学综述
ScientificWorldJournal. 2015;2015:596164. doi: 10.1155/2015/596164. Epub 2015 Jan 5.

引用本文的文献

1
Modern Treatments of Haemophilia: Review of Cost-Effectiveness Analyses and Future Directions.现代血友病治疗方法：成本效益分析的回顾与未来方向。
Pharmacoeconomics. 2018 Mar;36(3):263-284. doi: 10.1007/s40273-017-0588-z.
2
Measuring the quality of haemophilia care across different settings: a set of performance indicators derived from demographics data.衡量不同环境下血友病护理的质量：一组从人口统计学数据得出的绩效指标。
Haemophilia. 2017 Jan;23(1):e1-e7. doi: 10.1111/hae.13127. Epub 2016 Dec 8.
3
A population pharmacokinetic model for perioperative dosing of factor VIII in hemophilia A patients.
一种用于血友病A患者围手术期因子VIII给药的群体药代动力学模型。
Haematologica. 2016 Oct;101(10):1159-1169. doi: 10.3324/haematol.2015.136275. Epub 2016 Jul 6.
4
Using value-of-information methods when the disease is rare and the treatment is expensive--the example of hemophilia A.在疾病罕见且治疗昂贵的情况下使用信息价值方法——以甲型血友病为例。
J Gen Intern Med. 2014 Aug;29 Suppl 3(Suppl 3):S767-73. doi: 10.1007/s11606-014-2880-3.